https://orcid.org/0000-0002-2739-7357
References
- Bracaglia C, Prencipe G, De Benedetti F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J. 2017;15(1):5. doi:10.1186/s12969-016-0130-4
- Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55. doi:10.3389/fimmu.2019.00055
- Prakash PB, Raj S. Cytokine induced myocardial dysfunction in a patient with hemophagocytic lymphohistiocytosis. J Am Coll Cardiol. 2016;67(13_Supplement):1061. doi:10.1016/S0735-1097(16)31062-2
- Ravelli A, Minoia F, Davi S, et al. Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016;75(3):481–489. doi:10.1136/annrheumdis-2015-208982
- Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. doi:10.1002/pbc.21039
- Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22(5):561–566. doi:10.1097/01.bor.0000381996.69261.71
- Rőszer T. Understanding the mysterious m2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015;2015:816460. doi:10.1155/2015/816460
- Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15(1):172. doi:10.1186/s12916-017-0930-5
- Chizinga M, Kalra SS, Innabi A, Rackauskas M, Ataya A, Emtiazjoo A. Macrophage activating syndrome causing decompensated right heart failure. Respir Med Case Rep. 2021;33:101409. doi:10.1016/j.rmcr.2021.101409
- Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol. 2018;10:117–128. doi:10.2147/OARRR.S151013
- Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020;2(6):e358–e67. doi:10.1016/S2665-9913(20)30096-5
- Björkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Arch Orthop Trauma Surg. 2005;125(1):51–55. doi:10.1007/s00402-004-0760-8
- Björkman A, Svensson PJ, Hillarp A, Burtscher IM, Rünow A, Benoni G. Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res. 2004;425:168–172. doi:10.1097/00003086-200408000-00023
- Zhou JY, Martinez JA, Shen JP. Lamotrigine-induced hemophagocytic lymphohistiocytosis with Takotsubo cardiomyopathy: a case report. Journal of Medical Case Reports. 2019;13(1):345.
- Otillio JK, Harris JK, Tuuri R. A 6-year-old girl with undiagnosed hemophagocytic lymphohistiocytosis and takotsubo cardiomyopathy: a case report and review of the literature. Pediatr Emerg Care. 2014;30(8):561–565.
- Takeoka Y, Nakamae M, Nakamae H, et al. Two cases of ampulla (takotsubo-shaped) cardiomyopathy associated with hemophagocytic lymphohistiocytosis. Acta Haematol. 2007;117(4):205–210.
- Abdin A. Takotsubo Cardiomyopathy Due to Hemophagocytic Lymphohistiocytosis. CHEST. 2016;150(4):435A.
- Ullah W, Hamid M, Grover H, Figueredo VM, Inayat F. Takotsubo cardiomyopathy secondary to haemophagocytic lymphohistiocytosis in HIV patients: a comprehensive review. BMJ Case Rep. 2019;12(4).